A. | Financial Highlights | |
Condensed Consolidated Balance Sheets |
1 | |
Consolidated Statements of Operations |
2 | |
Quarterly Summary - Most Recent 8 Quarters |
3 | |
Non-GAAP Financial Measures | ||
Reconciliation from Net Income Available to Common Stockholders to Non-GAAP Operating Income (Loss) Available to Common Stockholders |
6 | |
Summary of Adjustments to Arrive at Non-GAAP Operating Income (Loss) Available to Common Stockholders |
7 | |
Quarterly Summary - Reconciliation from Net Income (Loss) Available to Common Stockholders to Non-GAAP Operating Income (Loss) Available to Common Stockholders |
8 | |
Quarterly Summary - Summary of Adjustments to Arrive at Non-GAAP Operating Income (Loss) Available to Common Stockholders |
10 | |
Capitalization/Book Value per Common Share |
11 | |
Spread Results |
13 | |
Investment Yields |
13 | |
B. | Product Summary | |
Summary of Cost of Money for Deferred Annuities |
14 | |
Annuity Account Balance Rollforward |
14 | |
MRB Liability |
15 | |
Account Values Subject to Recurring Fees Under Reinsurance Agreements |
15 | |
Annuity Deposits by Product Type |
16 | |
Surrender Charge Protection and Account Values by Product Type |
16 | |
Annuity Liability Characteristics |
17 | |
C. | Investment Summary | |
Summary of Invested Assets |
18 | |
Credit Quality of Fixed Maturity Securities |
18 | |
Watch List Securities |
19 | |
Fixed Maturity Securities by Sector |
20 | |
Mortgage Loans on Real Estate |
21 | |
D. |
Shareholder Information |
23 |
E. |
Research Analyst Coverage |
24 |
December 31, 2022 | December 31, 2021 | |||
Assets | ||||
Investments: | ||||
Fixed maturity securities, available for sale, at fair value | $ | 39,804,617 | $ | 51,305,943 |
Mortgage loans on real estate | 6,949,027 | 5,687,998 | ||
Real estate investments | 1,056,063 | 337,939 | ||
Limited partnerships and limited liability companies | 1,266,779 | 520,120 | ||
Derivative instruments | 431,727 | 1,277,480 | ||
Other investments | 1,817,085 | 1,247,024 | ||
Total investments | 51,325,298 | 60,376,504 | ||
Cash and cash equivalents | 1,919,669 | 4,508,982 | ||
Coinsurance deposits | 13,254,956 | 8,988,891 | ||
Accrued investment income | 497,851 | 445,097 | ||
Deferred policy acquisition costs | 2,773,643 | 3,062,204 | ||
Deferred sales inducements | 2,045,683 | 2,119,962 | ||
Deferred income taxes | 438,434 | - | ||
Income taxes recoverable | 55,498 | 166,586 | ||
Other assets | 872,567 | 875,396 | ||
Total assets | $ | 73,183,599 | $ | 80,543,622 |
Liabilities and Stockholders' Equity | ||||
Liabilities: | ||||
Policy benefit reserves | $ | 58,781,836 | $ | 62,614,822 |
Market risk benefits | 2,455,492 | 3,162,162 | ||
Other policy funds and contract claims | 512,790 | 226,844 | ||
Notes and loan payable | 792,073 | 496,250 | ||
Subordinated debentures | 78,753 | 78,421 | ||
Deferred income taxes | - | 914,417 | ||
Funds withheld for reinsurance liabilities | 6,577,426 | 3,124,740 | ||
Other liabilities | 1,614,479 | 2,187,249 | ||
Total liabilities | 70,812,849 | 72,804,905 | ||
Stockholders' equity: | ||||
Preferred stock, Series A | 16 | 16 | ||
Preferred stock, Series B | 12 | 12 | ||
Common stock | 84,810 | 92,514 | ||
Additional paid-in capital | 1,325,316 | 1,614,374 | ||
Accumulated other comprehensive income (loss) | (3,746,230) | 3,192,547 | ||
Retained earnings | 4,685,593 | 2,839,254 | ||
Total stockholders' equity attributable to American Equity Investment Life Holding Company | 2,349,517 | 7,738,717 | ||
Noncontrolling interests | 21,233 | - | ||
Total stockholders' equity | 2,370,750 | 7,738,717 | ||
Total liabilities and stockholders' equity | $ | 73,183,599 | $ | 80,543,622 |
Three Months Ended December 31, |
Year Ended December 31, | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Revenues: | ||||||||
Premiums and other considerations | $ | 2,991 | $ | 14,553 | $ | 19,739 | $ | 58,202 |
Annuity product charges | 61,666 | 60,310 | 230,354 | 242,631 | ||||
Net investment income | 537,995 | 514,599 | 2,307,463 | 2,037,475 | ||||
Change in fair value of derivatives | 22,243 | 522,251 | (1,138,128) | 1,348,735 | ||||
Net realized gains (losses) on investments | 14,411 | (10,478) | (47,848) | (13,242) | ||||
Other revenue | 13,032 | 8,263 | 42,245 | 16,160 | ||||
Total revenues | 652,338 | 1,109,498 | 1,413,825 | 3,689,961 | ||||
Benefits and expenses: | ||||||||
Insurance policy benefits and change in future policy benefits | 5,948 | 17,331 | 33,220 | 73,896 | ||||
Interest sensitive and index product benefits | 57,626 | 508,014 | 554,871 | 2,231,567 | ||||
Market risk benefits (gains) losses | 33,490 | 100,939 | 3,684 | 268,973 | ||||
Amortization of deferred sales inducements | 45,966 | 44,821 | 181,970 | 191,884 | ||||
Change in fair value of embedded derivatives | 342,409 | 186,802 | (2,352,598) | (358,302) | ||||
Interest expense on notes and loan payable | 10,228 | 6,259 | 32,098 | 25,581 | ||||
Interest expense on subordinated debentures | 1,335 | 1,330 | 5,331 | 5,324 | ||||
Amortization of deferred policy acquisition costs | 66,831 | 71,609 | 284,011 | 306,370 | ||||
Other operating costs and expenses | 62,389 | 65,812 | 239,526 | 241,882 | ||||
Total benefits and expenses | 626,222 | 1,002,917 | (1,017,887) | 2,987,175 | ||||
Income before income taxes | 26,116 | 106,581 | 2,431,712 | 702,786 | ||||
Income tax expense (benefit) | (6,817) | 19,615 | 511,135 | 149,763 | ||||
Net income | 32,933 | 86,966 | 1,920,577 | 553,023 | ||||
Less: Net income available to noncontrolling interests | 361 | - | 358 | - | ||||
Net income available to American Equity Investment Life Holding Company stockholders | 32,572 | 86,966 | 1,920,219 | 553,023 | ||||
Less: Preferred stock dividends | 10,919 | 10,919 | 43,675 | 43,675 | ||||
Net income available to American Equity Investment Life Holding Company common stockholders | $ | 21,653 | $ | 76,047 | $ | 1,876,544 | $ | 509,348 |
Earnings per common share | $ | 0.25 | $ | 0.82 | $ | 20.72 | $ | 5.43 |
Earnings per common share - assuming dilution | $ | 0.25 | $ | 0.81 | $ | 20.50 | $ | 5.39 |
Weighted average common shares outstanding (in thousands): | ||||||||
Earnings per common share | 85,274 | 92,479 | 90,558 | 93,860 | ||||
Earnings per common share - assuming dilution | 86,402 | 93,378 | 91,538 | 94,491 |
Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | |||||
Revenues: | ||||||||
Traditional life insurance premiums | $ | 626 | $ | 634 | $ | 691 | $ | 675 |
Life contingent immediate annuity considerations | 2,365 | 2,205 | 3,140 | 9,403 | ||||
Surrender charges | 22,030 | 19,783 | 15,345 | 15,541 | ||||
Lifetime income benefit rider fees | 39,636 | 41,036 | 40,169 | 36,814 | ||||
Net investment income | 537,995 | 609,737 | 592,308 | 567,423 | ||||
Change in fair value of derivatives | 22,243 | (176,671) | (506,181) | (477,519) | ||||
Net realized gains (losses) on investments | 14,411 | (15,860) | (33,272) | (13,127) | ||||
Other revenue (a) | 13,032 | 10,988 | 9,408 | 8,817 | ||||
Total revenues | 652,338 | 491,852 | 121,608 | 148,027 | ||||
Benefits and expenses: | ||||||||
Traditional life insurance policy benefits and change in future policy benefits (b) | 944 | 118 | 495 | 1,491 | ||||
Life contingent immediate annuity benefits and change in future policy benefits (c) | 5,004 | 6,541 | 6,503 | 12,124 | ||||
Interest sensitive and index product benefits | 57,626 | 68,982 | 140,346 | 287,917 | ||||
Market risk benefits (gains) losses (d) | 33,490 | 77,579 | (299,278) | 191,893 | ||||
Amortization of deferred sales inducements | 45,966 | 46,223 | 44,696 | 45,085 | ||||
Change in fair value of embedded derivatives (e) | 342,409 | (415,374) | (885,984) | (1,393,649) | ||||
Interest expense on notes payable | 10,228 | 8,984 | 6,461 | 6,425 | ||||
Interest expense on subordinated debentures | 1,335 | 1,333 | 1,346 | 1,317 | ||||
Amortization of deferred policy acquisition costs | 66,831 | 71,726 | 72,485 | 72,969 | ||||
Other operating costs and expenses | 62,389 | 59,470 | 59,872 | 57,795 | ||||
Total benefits and expenses | 626,222 | (74,418) | (853,058) | (716,633) | ||||
Income before income taxes | 26,116 | 566,270 | 974,666 | 864,660 | ||||
Income tax expense (benefit) | (6,817) | 121,380 | 211,377 | 185,195 | ||||
Net income (b)(c)(d)(e) | 32,933 | 444,890 | 763,289 | 679,465 | ||||
Less: Net income (loss) available to noncontrolling interests | 361 | 1 | (4) | - | ||||
Net income available to American Equity Investment Life Holding Company stockholders (b)(c)(d)(e) | 32,572 | 444,889 | 763,293 | 679,465 | ||||
Less: Preferred stock dividends | 10,919 | 10,918 | 10,919 | 10,919 | ||||
Net income available to American Equity Investment Life Holding Company common stockholders (b)(c)(d)(e) | $ | 21,653 | $ | 433,971 | $ | 752,374 | $ | 668,546 |
Earnings per common share | $ | 0.25 | $ | 4.95 | $ | 8.13 | $ | 6.90 |
Earnings per common share - assuming dilution (b)(c)(d)(e) | $ | 0.25 | $ | 4.90 | $ | 8.06 | $ | 6.83 |
Weighted average common shares outstanding (thousands): | ||||||||
Earnings per common share | 85,274 | 87,707 | 92,544 | 96,866 | ||||
Earnings per common share - assuming dilution | 86,402 | 88,581 | 93,375 | 97,953 |
Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | |||||
Revenues: | ||||||||
Traditional life insurance premiums | $ | 677 | $ | 697 | $ | 708 | $ | 706 |
Life contingent immediate annuity considerations | 13,876 | 15,144 | 13,887 | 12,507 | ||||
Surrender charges | 13,638 | 16,481 | 18,057 | 19,481 | ||||
Lifetime income benefit rider fees | 46,672 | 41,999 | 45,702 | 40,601 | ||||
Net investment income | 514,599 | 526,366 | 499,320 | 497,190 | ||||
Change in fair value of derivatives | 522,251 | (70,701) | 500,880 | 396,305 | ||||
Net realized gains (losses) on investments | (10,478) | 4,933 | (3,114) | (4,583) | ||||
Other revenue (a) | 8,263 | 7,897 | - | - | ||||
Total revenues | 1,109,498 | 542,816 | 1,075,440 | 962,207 | ||||
Benefits and expenses: | ||||||||
Traditional life insurance policy benefits and change in future policy benefits (b) | 60 | (3,971) | 443 | 949 | ||||
Life contingent immediate annuity benefits and change in future policy benefits (c) | 17,271 | 26,622 | 16,656 | 15,866 | ||||
Interest sensitive and index product benefits | 508,014 | 540,883 | 778,810 | 403,860 | ||||
Market risk benefits (gains) losses (d) | 100,939 | 310,544 | 252,412 | (394,922) | ||||
Amortization of deferred sales inducements | 44,821 | 45,219 | 50,719 | 51,125 | ||||
Change in fair value of embedded derivatives (e) | 186,802 | (536,404) | 273,713 | (282,413) | ||||
Interest expense on notes payable | 6,259 | 6,535 | 6,394 | 6,393 | ||||
Interest expense on subordinated debentures | 1,330 | 1,342 | 1,326 | 1,326 | ||||
Amortization of deferred policy acquisition costs | 71,609 | 71,201 | 82,017 | 81,543 | ||||
Other operating costs and expenses | 65,812 | 56,020 | 64,590 | 55,460 | ||||
Total benefits and expenses | 1,002,917 | 517,991 | 1,527,080 | (60,813) | ||||
Income (loss) before income taxes | 106,581 | 24,825 | (451,640) | 1,023,020 | ||||
Income tax expense (benefit) | 19,615 | 8,421 | (95,787) | 217,514 | ||||
Net income (loss) (b)(c)(d)(e) | 86,966 | 16,404 | (355,853) | 805,506 | ||||
Less: Net income (loss) available to noncontrolling interests | - | - | - | - | ||||
Net income (loss) available to American Equity Investment Life Holding Company stockholders (b)(c)(d)(e) | 86,966 | 16,404 | (355,853) | 805,506 | ||||
Less: Preferred stock dividends | 10,919 | 10,918 | 10,919 | 10,919 | ||||
Net income (loss) available to American Equity Investment Life Holding Company common stockholders (b)(c)(d)(e) | $ | 76,047 | $ | 5,486 | $ | (366,772) | $ | 794,587 |
Earnings (loss) per common share | $ | 0.82 | $ | 0.06 | $ | (3.87) | $ | 8.30 |
Earnings (loss) per common share - assuming dilution (b)(c)(d)(e) | $ | 0.81 | $ | 0.06 | $ | (3.87) | $ | 8.26 |
Weighted average common shares outstanding (thousands): | ||||||||
Earnings (loss) per common share | 92,479 | 92,478 | 94,801 | 95,735 | ||||
Earnings (loss) per common share - assuming dilution | 93,378 | 93,044 | 95,379 | 96,216 |
Three Months Ended December 31, |
Year Ended December 31, | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Net income available to American Equity Investment Life Holding Company common stockholders | $ | 21,653 | $ | 76,047 | $ | 1,876,544 | $ | 509,348 |
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | ||||||||
Net realized (gains) losses on financial assets, including credit losses | (19,460) | 10,045 | 48,264 | 13,618 | ||||
Change in fair value of derivatives and embedded derivatives | 169,767 | (29,158) | (1,549,205) | (316,765) | ||||
Capital markets impact on the change in fair value of market risk benefits | 2,309 | 22,119 | (393,617) | (371,935) | ||||
Net investment income | 1,476 | - | 1,476 | - | ||||
Other revenue | 5,969 | - | 5,969 | - | ||||
Income taxes | (39,998) | (4,539) | 401,838 | 143,806 | ||||
Non-GAAP operating income (loss) available to common stockholders | $ | 141,716 | $ | 74,514 | $ | 391,269 | $ | (21,928) |
Impact of excluding notable items (a) | $ | - | $ | 10,265 | $ | 181,890 | $ | 317,425 |
Per common share - assuming dilution: | ||||||||
Net income available to American Equity Investment Life Holding Company common stockholders | $ | 0.25 | $ | 0.81 | $ | 20.50 | $ | 5.39 |
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | ||||||||
Anti-dilutive impact for losses (b) | - | - | - | 0.01 | ||||
Net realized (gains) losses on financial assets, including credit losses | (0.23) | 0.11 | 0.53 | 0.14 | ||||
Change in fair value of derivatives and embedded derivatives | 1.96 | (0.31) | (16.92) | (3.35) | ||||
Capital markets impact on the change in fair value of market risk benefits | 0.03 | 0.24 | (4.30) | (3.94) | ||||
Net investment income | 0.02 | - | 0.01 | - | ||||
Other revenue | 0.07 | - | 0.06 | - | ||||
Income taxes | (0.46) | (0.05) | 4.39 | 1.52 | ||||
Non-GAAP operating income (loss) available to common stockholders | $ | 1.64 | $ | 0.80 | $ | 4.27 | $ | (0.23) |
Impact of excluding notable items (a) | $ | - | $ | 0.11 | $ | 1.99 | $ | 3.36 |
Three Months Ended December 31, |
Year Ended December 31, | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Notable items impacting non-GAAP operating income (loss) available to common stockholders: | ||||||||
Impact of actuarial assumption updates | $ | - | $ | 10,265 | $ | 181,890 | $ | 317,425 |
Total notable items (a) | $ | - | $ | 10,265 | $ | 181,890 | $ | 317,425 |
Three Months Ended December 31, |
Year Ended December 31, | |||||||
2022 | 2021 | 2022 | 2021 | |||||
Net realized (gains) losses on financial assets, including credit losses: | ||||||||
Net realized (gains) losses on financial assets, including credit losses | $ | (19,460) | $ | 10,045 | $ | 48,264 | $ | 13,618 |
Income taxes | 4,183 | (2,160) | (10,377) | (2,928) | ||||
$ | (15,277) | $ | 7,885 | $ | 37,887 | $ | 10,690 | |
Change in fair value of derivatives and embedded derivatives: | ||||||||
Fixed index annuities | $ | 89,662 | $ | (26,796) | $ | (1,129,326) | $ | (314,403) |
Reinsurance contracts | 78,594 | (2,362) | (439,502) | (2,362) | ||||
Interest rate swaps | 1,511 | - | 19,623 | - | ||||
Income taxes | (42,083) | 2,376 | 329,188 | 66,768 | ||||
$ | 127,684 | $ | (26,782) | $ | (1,220,017) | $ | (249,997) | |
Capital markets impact on the fair value of market risk benefits: | ||||||||
Capital markets impact on the change in fair value of market risk benefits | $ | (16,236) | $ | 14,143 | $ | (449,887) | $ | (405,610) |
Amortization of capital markets impact on the fair value of market risk benefits | 18,545 | 7,976 | 56,270 | 33,675 | ||||
Income taxes | (498) | (4,755) | 84,627 | 79,966 | ||||
$ | 1,811 | $ | 17,364 | $ | (308,990) | $ | (291,969) | |
Net investment income: | ||||||||
Income associated with assets transferred under reinsurance treaty | $ | 1,476 | $ | - | $ | 1,476 | $ | - |
Income taxes | (317) | - | (317) | - | ||||
$ | 1,159 | $ | - | $ | 1,159 | $ | - | |
Other revenue: | ||||||||
Amortization of deferred fees associated with reinsurance treaties | $ | 5,969 | $ | - | $ | 5,969 | $ | - |
Income taxes | (1,283) | - | (1,283) | - | ||||
$ | 4,686 | $ | - | $ | 4,686 | $ | - |
Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | |||||
Net income (loss) available to American Equity Investment Life Holding Company common stockholders | $ | 21,653 | $ | 433,971 | $ | 752,374 | $ | 668,546 |
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | ||||||||
Net realized (gains) losses on financial assets, including credit losses | (19,460) | 16,945 | 37,054 | 13,725 | ||||
Change in fair value of derivatives and embedded derivatives | 169,767 | (400,952) | (470,813) | (847,207) | ||||
Capital markets impact on the change in fair value of market risk benefits | 2,309 | (179,509) | (335,330) | 118,913 | ||||
Net investment income | 1,476 | - | - | - | ||||
Other revenue | 5,969 | - | - | - | ||||
Income taxes | (39,998) | 120,802 | 167,944 | 153,090 | ||||
Non-GAAP operating income (loss) available to common stockholders | $ | 141,716 | $ | (8,743) | $ | 151,229 | $ | 107,067 |
Impact of excluding notable items (a) | $ | - | $ | 181,890 | $ | - | $ | - |
Per common share - assuming dilution: | ||||||||
Net income (loss) available to American Equity Investment Life Holding Company common stockholders | $ | 0.25 | $ | 4.90 | $ | 8.06 | $ | 6.83 |
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | ||||||||
Anti-dilutive impact for losses (b) | - | - | - | - | ||||
Net realized (gains) losses on financial assets, including credit losses | (0.23) | 0.19 | 0.39 | 0.14 | ||||
Change in fair value of derivatives and embedded derivatives | 1.96 | (4.52) | (5.04) | (8.65) | ||||
Capital markets impact on the change in fair value of market risk benefits | 0.03 | (2.03) | (3.59) | 1.21 | ||||
Net investment income | 0.02 | - | - | - | ||||
Other revenue | 0.07 | - | - | - | ||||
Income taxes | (0.46) | 1.36 | 1.80 | 1.56 | ||||
Non-GAAP operating income (loss) available to common stockholders | $ | 1.64 | $ | (0.10) | $ | 1.62 | $ | 1.09 |
Impact of excluding notable items (a) | $ | - | $ | 2.05 | $ | - | $ | - |
Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | |||||
Notable items impacting non-GAAP operating income (loss) available to common stockholders: | ||||||||
Impact of actuarial assumption updates | $ | - | $ | 181,890 | $ | - | $ | - |
Total notable items (a) | $ | - | $ | 181,890 | $ | - | $ | - |
Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | |||||
Net income (loss) available to American Equity Investment Life Holding Company common stockholders | $ | 76,047 | $ | 5,486 | $ | (366,772) | $ | 794,587 |
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | ||||||||
Net realized (gains) losses on financial assets, including credit losses | 10,045 | (4,016) | 2,862 | 4,727 | ||||
Change in fair value of derivatives and embedded derivatives | (29,158) | (125,076) | 331,269 | (493,800) | ||||
Capital markets impact on the change in fair value of market risk benefits | 22,119 | (138,995) | 206,951 | (462,010) | ||||
Net investment income | - | - | - | - | ||||
Other revenue | - | - | - | - | ||||
Income taxes | (4,539) | 61,496 | (114,858) | 201,707 | ||||
Non-GAAP operating income (loss) available to common stockholders | $ | 74,514 | $ | (201,105) | $ | 59,452 | $ | 45,211 |
Impact of excluding notable items (a) | $ | 10,265 | $ | 307,159 | $ | - | $ | - |
Per common share - assuming dilution: | ||||||||
Net income (loss) available to American Equity Investment Life Holding Company common stockholders | $ | 0.81 | $ | 0.06 | $ | (3.87) | $ | 8.26 |
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: | ||||||||
Anti-dilutive impact for losses (b) | - | 0.01 | 0.02 | - | ||||
Net realized (gains) losses on financial assets, including credit losses | 0.11 | (0.05) | 0.03 | 0.05 | ||||
Change in fair value of derivatives and embedded derivatives | (0.31) | (1.35) | 3.47 | (5.13) | ||||
Capital markets impact on the change in fair value of market risk benefits | 0.24 | (1.50) | 2.17 | (4.80) | ||||
Net investment income | - | - | - | - | ||||
Other revenue | - | - | - | - | ||||
Income taxes | (0.05) | 0.66 | (1.20) | 2.09 | ||||
Non-GAAP operating income (loss) available to common stockholders | $ | 0.80 | $ | (2.17) | $ | 0.62 | $ | 0.47 |
Impact of excluding notable items (a) | $ | 0.11 | $ | 3.30 | $ | - | $ | - |
Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | |||||
Notable items impacting non-GAAP operating income (loss) available to common stockholders: | ||||||||
Impact of actuarial assumption updates | $ | 10,265 | $ | 307,159 | $ | - | $ | - |
Total notable items (a) | $ | 10,265 | $ | 307,159 | $ | - | $ | - |
Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | |||||
Net realized (gains) losses on investments | $ | (14,411) | $ | 15,860 | $ | 33,272 | $ | 13,127 |
Net investment income | 1,476 | - | - | - | ||||
Other revenue | 5,969 | - | - | - | ||||
Change in fair value of derivatives | (172,643) | 14,423 | 415,171 | 546,442 | ||||
Increase (decrease) in total revenues | (179,609) | 30,283 | 448,443 | 559,569 | ||||
Change in fair value of embedded derivatives | (342,409) | 415,374 | 885,984 | 1,393,649 | ||||
Market risk benefits (gains) losses | (2,309) | 179,509 | 335,330 | (118,913) | ||||
Interest sensitive and index product benefits (a) | 5,048 | (1,084) | (3,782) | (598) | ||||
Increase (decrease) in total benefits and expenses | (339,670) | 593,799 | 1,217,532 | 1,274,138 | ||||
Increase (decrease) in income (loss) before income taxes | 160,061 | (563,516) | (769,089) | (714,569) | ||||
Increase (decrease) in income tax expense benefit | 39,998 | (120,802) | (167,944) | (153,090) | ||||
Increase (decrease) in net income (loss) available to common stockholders | $ | 120,063 | $ | (442,714) | $ | (601,145) | $ | (561,479) |
Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | |||||
Net realized (gains) losses on investments | $ | 10,478 | $ | (4,933) | $ | 3,114 | $ | 4,583 |
Net investment income | - | - | - | - | ||||
Other revenue | - | - | - | - | ||||
Change in fair value of derivatives | (215,962) | 411,329 | 57,556 | (211,387) | ||||
Increase (decrease) in total revenues | (205,484) | 406,396 | 60,670 | (206,804) | ||||
Change in fair value of embedded derivatives | (186,802) | 536,404 | (273,713) | 282,413 | ||||
Market risk benefits (gains) losses | (22,119) | 138,995 | (206,951) | 462,010 | ||||
Interest sensitive and index product benefits (a) | 431 | (916) | 252 | (144) | ||||
Increase (decrease) in total benefits and expenses | (208,490) | 674,483 | (480,412) | 744,279 | ||||
Increase (decrease) in income (loss) before income taxes | 3,006 | (268,087) | 541,082 | (951,083) | ||||
Increase (decrease) in income tax expense benefit | 4,539 | (61,496) | 114,858 | (201,707) | ||||
Increase (decrease) in net income (loss) available to common stockholders | $ | (1,533) | $ | (206,591) | $ | 426,224 | $ | (749,376) |
Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | |||||
Capitalization: | ||||||||
Notes and loan payable | $ | 800,000 | $ | 800,000 | $ | 500,000 | $ | 500,000 |
Subordinated debentures payable to subsidiary trusts | 78,753 | 78,668 | 78,584 | 78,502 | ||||
Total debt
| 878,753 | 878,668 | 578,584 | 578,502 | ||||
Total stockholders' equity attributable to American Equity Investment Life Holding Company | 2,349,517 | 2,157,667 | 3,625,377 | 5,718,944 | ||||
Total capitalization | 3,228,270 | 3,036,335 | 4,203,961 | 6,297,446 | ||||
Accumulated other comprehensive (income) loss (AOCI) | 3,746,230 | 3,984,496 | 2,231,594 | (426,490) | ||||
Total capitalization excluding AOCI (a)
| $ | 6,974,500 | $ | 7,020,831 | $ | 6,435,555 | $ | 5,870,956 |
Total stockholders' equity attributable to American Equity Investment Life Holding Company | $ | 2,349,517 | $ | 2,157,667 | $ | 3,625,377 | $ | 5,718,944 |
Equity available to preferred stockholders (b) | (700,000) | (700,000) | (700,000) | (700,000) | ||||
Total common stockholders' equity (c)
| 1,649,517 | 1,457,667 | 2,925,377 | 5,018,944 | ||||
Accumulated other comprehensive (income) loss | 3,746,230 | 3,984,496 | 2,231,594 | (426,490) | ||||
Total common stockholders' equity excluding AOCI (c)
| 5,395,747 | 5,442,163 | 5,156,971 | 4,592,454 | ||||
Net impact of fair value accounting for derivatives and embedded derivatives | (1,652,169) | (1,721,324) | (1,418,244) | (1,051,245) | ||||
Net capital markets impact on the fair value of market risk benefits | (600,958) | (602,772) | (461,856) | (198,622) | ||||
Total common stockholders' equity excluding AOCI and the net impact of fair value accounting for fixed index annuities (c)
| $ | 3,142,620 | $ | 3,118,067 | $ | 3,276,871 | $ | 3,342,587 |
Common shares outstanding | 84,810,255 | 85,966,505 | 90,168,512 | 95,019,904 | ||||
Book Value per Common Share: (d)
| ||||||||
Book value per common share | $ | 19.45 | $ | 16.96 | $ | 32.44 | $ | 52.82 |
Book value per common share excluding AOCI (c) | $ | 63.62 | $ | 63.31 | $ | 57.19 | $ | 48.33 |
Book value per common share excluding AOCI and the net impact of fair value accounting for fixed index annuities (c) | $ | 37.05 | $ | 36.27 | $ | 36.34 | $ | 35.18 |
Debt-to-Capital Ratios: (e)
| ||||||||
Senior debt / Total capitalization | 11.5 | % | 11.4 | % | 7.8 | % | 8.5 | % |
Total debt / Total capitalization | 12.6 | % | 12.5 | % | 9.0 | % | 9.9 | % |
Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | |||||
Capitalization: | ||||||||
Notes and loan payable | $ | 500,000 | $ | 500,000 | $ | 500,000 | $ | 500,000 |
Subordinated debentures payable to subsidiary trusts | 78,421 | 78,342 | 78,264 | 78,187 | ||||
Total debt
| 578,421 | 578,342 | 578,264 | 578,187 | ||||
Total stockholders' equity attributable to American Equity Investment Life Holding Company | 7,738,717 | 7,799,987 | 8,075,883 | 7,623,297 | ||||
Total capitalization | 8,317,138 | 8,378,329 | 8,654,147 | 8,201,484 | ||||
Accumulated other comprehensive (income) loss (AOCI) | (3,192,547) | (3,303,752) | (3,589,584) | (2,684,172) | ||||
Total capitalization excluding AOCI (a)
| $ | 5,124,591 | $ | 5,074,577 | $ | 5,064,563 | $ | 5,517,312 |
Total stockholders' equity attributable to American Equity Investment Life Holding Company | $ | 7,738,717 | $ | 7,799,987 | $ | 8,075,883 | $ | 7,623,297 |
Equity available to preferred stockholders (b) | (700,000) | (700,000) | (700,000) | (700,000) | ||||
Total common stockholders' equity (c)
| 7,038,717 | 7,099,987 | 7,375,883 | 6,923,297 | ||||
Accumulated other comprehensive (income) loss | (3,192,547) | (3,303,752) | (3,589,584) | (2,684,172) | ||||
Total common stockholders' equity excluding AOCI (c)
| 3,846,170 | 3,796,235 | 3,786,299 | 4,239,125 | ||||
Net impact of fair value accounting for derivatives and embedded derivatives | (383,284) | (358,862) | (332,010) | (593,531) | ||||
Net capital markets impact on the fair value of market risk benefits | (291,696) | (309,332) | (200,221) | (362,677) | ||||
Total common stockholders' equity excluding AOCI and the net impact of fair value accounting for fixed index annuities (c)
| $ | 3,171,190 | $ | 3,128,041 | $ | 3,254,068 | $ | 3,282,917 |
Common shares outstanding | 92,513,517 | 92,513,517 | 92,553,825 | 95,482,733 | ||||
Book Value per Common Share: (d)
| ||||||||
Book value per common share | $ | 76.08 | $ | 76.75 | $ | 79.69 | $ | 72.51 |
Book value per common share excluding AOCI (c) | $ | 41.57 | $ | 41.03 | $ | 40.91 | $ | 44.40 |
Book value per common share excluding AOCI and the net impact of fair value accounting for fixed index annuities (c) | $ | 34.28 | $ | 33.81 | $ | 35.16 | $ | 34.38 |
Debt-to-Capital Ratios: (e)
| ||||||||
Senior debt / Total capitalization | 9.8 | % | 9.9 | % | 9.9 | % | 9.1 | % |
Total debt / Total capitalization | 11.3 | % | 11.4 | % | 11.4 | % | 10.5 | % |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
4.34% | 3.73% | Average yield on invested assets | 4.30% | 4.48% | 4.33% | 4.15% | 3.80% | |||||||
1.71% | 1.55% | Aggregate cost of money | 1.76% | 1.75% | 1.69% | 1.64% | 1.51% | |||||||
2.63% | 2.18% | Aggregate investment spread | 2.54% | 2.73% | 2.64% | 2.51% | 2.29% | |||||||
Impact of: | ||||||||||||||
0.03% | 0.11% |
Investment yield - additional prepayment income
| 0.01% | 0.03% | 0.05% | 0.03% | 0.12% | |||||||
0.01% | 0.07% | Cost of money effect of over hedging | -% | -% | 0.02% | 0.03% | 0.14% | |||||||
$ | 53,225,871 | $ | 54,750,862 | Weighted average investments | $ | 50,040,228 | $ | 54,378,154 | $ | 54,768,966 | $ | 54,728,239 | $ | 54,407,554 |
49,811,623 | 54,617,968 | Ending investments | 49,811,623 | 54,056,886 | 54,699,422 | 54,838,509 | 54,617,968 |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
Investment income: | ||||||||||||||
$ | 2,108,088 | $ | 1,967,496 |
Fixed income (a)
| $ | 511,077 | $ | 547,326 | $ | 539,382 | $ | 510,303 | $ | 500,577 |
200,349 | 73,990 | Mark-to-market private asset income (a) | 26,816 | 61,671 | 53,816 | 58,046 | 16,596 | |||||||
$ | 2,308,437 | $ | 2,041,486 | Total non-GAAP investment income (b) | $ | 537,893 | $ | 608,997 | $ | 593,198 | $ | 568,349 | $ | 517,173 |
Investment yield: | ||||||||||||||
4.08% | 3.62% | Fixed income investment yield | 4.26% | 4.16% | 4.04% | 3.80% | 3.73% | |||||||
12.95% | 16.53% | Mark-to-market private asset yield | 5.29% | 13.89% | 15.15% | 22.36% | 9.60% | |||||||
4.34% | 3.73% | Total investment yield | 4.30% | 4.48% | 4.33% | 4.15% | 3.80% | |||||||
Weighted average investments: | ||||||||||||||
$ | 51,678,469 | $ | 54,303,353 | Fixed income investments | $ | 48,012,311 | $ | 52,602,319 | $ | 53,347,874 | $ | 53,689,782 | $ | 53,716,356 |
1,547,402 | 447,509 | Mark-to-market private assets | 2,027,917 | 1,775,835 | 1,421,092 | 1,038,457 | 691,199 | |||||||
$ | 53,225,871 | $ | 54,750,862 | Total weighted average investments | $ | 50,040,228 | $ | 54,378,154 | $ | 54,768,966 | $ | 54,728,239 | $ | 54,407,555 |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
Included in interest sensitive and index product benefits:
| ||||||||||||||
$ | 305,292 | $ | 1,977,888 | Index credits | $ | 3,861 | $ | 4,648 | $ | 72,398 | $ | 224,385 | $ | 442,568 |
240,889 | 245,892 | Interest credited | 56,402 | 62,383 | 60,770 | 61,334 | 63,974 | |||||||
Included in change in fair value of derivatives:
| ||||||||||||||
(312,133) | (2,019,477) | Proceeds received at option expiration | (4,061) | (4,865) | (75,115) | (228,092) | (459,982) | |||||||
647,132 | 630,015 | Pro rata amortization of option cost | 154,463 | 167,197 | 165,375 | 160,097 | 153,399 | |||||||
$ | 881,180 | $ | 834,318 | Cost of money for deferred annuities | $ | 210,665 | $ | 229,363 | $ | 223,428 | $ | 217,724 | $ | 199,959 |
$ | 51,558,865 | $ | 53,681,684 |
Weighted average liability balance outstanding
| $ | 47,802,219 | $ | 52,337,208 | $ | 52,940,739 | $ | 53,155,293 | $ | 53,064,893 |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
$ | 53,191,277 | $ | 54,056,725 | Account balances at beginning of period | $ | 51,913,689 | $ | 52,762,558 | $ | 53,119,291 | $ | 53,191,277 | $ | 52,938,493 |
(4,068,761) | (4,279,394) | Reserves ceded - in-force | (3,810,982) | (257,779) | - | - | - | |||||||
49,122,516 | 49,777,331 | Account balance at beginning of period, net of reinsurance ceded | 48,102,707 | 52,504,779 | 53,119,291 | 53,191,277 | 52,938,493 | |||||||
2,347,315 | 5,485,205 | Net deposits | 613,084 | 496,940 | 562,366 | 674,925 | 815,890 | |||||||
107,691 | 95,160 | Premium bonuses | 33,617 | 27,385 | 23,547 | 23,142 | 23,476 | |||||||
546,181 | 2,223,780 | Fixed interest credited and index credits | 60,263 | 67,031 | 133,168 | 285,719 | 506,542 | |||||||
(72,699) | (67,657) | Surrender charges | (22,030) | (19,783) | (15,345) | (15,541) | (13,638) | |||||||
(157,655) | (174,974) | Lifetime income benefit rider fees | (39,636) | (41,036) | (40,169) | (36,814) | (46,672) | |||||||
(4,388,734) | (4,147,568) | Surrenders, withdrawals, deaths, etc. | (1,243,390) | (1,121,627) | (1,020,300) | (1,003,417) | (1,032,814) | |||||||
$ | 47,504,615 | $ | 53,191,277 | Account balances at end of period | $ | 47,504,615 | $ | 51,913,689 | $ | 52,762,558 | $ | 53,119,291 | $ | 53,191,277 |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
$ | 2,362,947 | $ | 2,136,146 | MRB balance at beginning of period | $ | 1,762,629 | $ | 1,721,376 | $ | 2,075,033 | $ | 2,362,947 | $ | 2,288,670 |
(326,524) | (63,215) | Reserves ceded - in-force | (331,020) | 4,496 | - | - | - | |||||||
7,429 | (5,236) | Issuances | 1,230 | 1,366 | 913 | 3,920 | 1,290 | |||||||
66,198 | 40,186 | Interest accrual | 23,910 | 20,626 | 12,424 | 9,238 | 11,772 | |||||||
102,665 | 114,178 | Attributed fees collected | 25,933 | 25,484 | 25,627 | 25,621 | 28,213 | |||||||
- | - | Benefits payments | - | - | - | - | - | |||||||
(449,887) | (405,610) | Effect of changes in interest rates and equity markets | (16,236) | (197,978) | (348,675) | 113,002 | 14,142 | |||||||
278,651 | 527,984 | Effect of changes in assumptions and policyholder behavior | (1,371) | 228,048 | 10,971 | 41,003 | 46,567 | |||||||
(519,525) | 18,514 | Effect of changes in instrument specific credit risk | 56,879 | (40,789) | (54,917) | (480,698) | (27,707) | |||||||
1,521,954 | 2,362,947 | MRB balance at end of period, net (a) | 1,521,954 | 1,762,629 | 1,721,376 | 2,075,033 | 2,362,947 | |||||||
765,552 | 371,935 | MRB net deferred capital markets impact, end of period | 765,552 | 767,862 | 588,352 | 253,022 | 371,935 | |||||||
$ | 2,287,506 | $ | 2,734,882 | Non-GAAP MRB balance, end of period (b) | $ | 2,287,506 | $ | 2,530,491 | $ | 2,309,728 | $ | 2,328,055 | $ | 2,734,882 |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
$ | 4,660,690 | $ | - | Account value of business ceded subject to fee income at beginning of period | $ | 5,612,098 | $ | 5,065,538 | $ | 4,859,360 | $ | 4,660,690 | $ | 4,459,858 |
4,068,761 | 4,279,394 | In-force account value ceded subject to fee income | 3,810,982 | 257,779 | - | - | - | |||||||
1,045,600 | 381,296 | Premiums on business ceded subject to fee income | 351,971 | 288,781 | 206,178 | 198,670 | 200,832 | |||||||
(132,715) | - | Disbursements on business ceded subject to fee income | (132,715) | - | - | - | - | |||||||
$ | 9,642,336 | $ | 4,660,690 | Account value of business ceded subject to fee income at end of period | $ | 9,642,336 | $ | 5,612,098 | $ | 5,065,538 | $ | 4,859,360 | $ | 4,660,690 |
$ | 48,214 | $ | 16,160 | Non-GAAP operating revenue associated with recurring fees (a) | $ | 19,001 | $ | 10,988 | $ | 9,408 | $ | 8,817 | $ | 8,263 |
Year Ended December 31, | ||||||||||||||
2022 | 2021 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | ||||||||
American Equity Life: | ||||||||||||||
$ | 2,692,141 | $ | 2,753,479 | Fixed index annuities | $ | 637,021 | $ | 627,444 | $ | 671,696 | $ | 755,980 | $ | 806,238 |
5,329 | 6,133 | Annual reset fixed rate annuities | 1,856 | 1,271 | 1,140 | 1,062 | 848 | |||||||
56,511 | 855,702 | Multi-year fixed rate annuities | 49,216 | 4,465 | 485 | 2,345 | 6,640 | |||||||
18,935 | 59,816 | Single premium immediate annuities | 494 | 1,915 | 3,073 | 13,453 | 14,145 | |||||||
2,772,916 | 3,675,130 | 688,587 | 635,095 | 676,394 | 772,840 | 827,871 | ||||||||
Eagle Life: | ||||||||||||||
479,279 | 697,068 | Fixed index annuities | 145,772 | 102,379 | 104,374 | 126,754 | 176,101 | |||||||
380 | 350 | Annual reset fixed rate annuities | 230 | 143 | - | 7 | 13 | |||||||
82,581 | 1,597,292 | Multi-year fixed rate annuities | 65,434 | 14,684 | 123 | 2,340 | 40,901 | |||||||
562,240 | 2,294,710 | 211,436 | 117,206 | 104,497 | 129,101 | 217,015 | ||||||||
Consolidated: | ||||||||||||||
3,171,420 | 3,450,547 | Fixed index annuities | 782,793 | 729,823 | 776,070 | 882,734 | 982,339 | |||||||
5,709 | 6,483 | Annual reset fixed rate annuities | 2,086 | 1,414 | 1,140 | 1,069 | 861 | |||||||
139,092 | 2,452,994 | Multi-year fixed rate annuities | 114,650 | 19,149 | 608 | 4,685 | 47,541 | |||||||
18,935 | 59,816 | Single premium immediate annuities | 494 | 1,915 | 3,073 | 13,453 | 14,145 | |||||||
3,335,156 | 5,969,840 | Total before coinsurance ceded | 900,023 | 752,301 | 780,891 | 901,941 | 1,044,886 | |||||||
968,906 | 424,819 | Coinsurance ceded | 286,445 | 253,446 | 215,452 | 213,563 | 214,851 | |||||||
$ | 2,366,250 | $ | 5,545,021 | Net after coinsurance ceded | $ | 613,578 | $ | 498,855 | $ | 565,439 | $ | 688,378 | $ | 830,035 |
Surrender Charge | Net Account Value | ||||||
Product Type |
Avg. Years At Issue |
Avg. Years Remaining |
Avg. % Remaining | Dollars in Thousands | % | ||
Fixed Index Annuities | 12.5 | 5.0 | 8.1% | $ | 41,992,352 | 88.4 | % |
Annual Reset Fixed Rate Annuities | 7.4 | 1.7 | 3.4% | 1,247,151 | 2.6 | % | |
Multi-Year Fixed Rate Annuities | 3.9 | 1.7 | 7.4% | 4,265,112 | 9.0 | % | |
Total | 11.6 | 4.6 | 7.9% | $ | 47,504,615 | 100.0 | % |
Surrender Charge Percentages: |
Fixed Annuities Account Value |
Fixed Index Annuities Account Value | ||
No surrender charge | $ | 898,320 | $ | 3,616,403 |
0.0% < 2.0% | 41,672 | 2,062,990 | ||
2.0% < 3.0% | 65,004 | 4,321,344 | ||
3.0% < 4.0% | 68,626 | 982,289 | ||
4.0% < 5.0% | 6,436 | 2,772,450 | ||
5.0% < 6.0% | 36,179 | 2,608,334 | ||
6.0% < 7.0% | 71,838 | 2,548,367 | ||
7.0% < 8.0% | 1,420,984 | 2,812,800 | ||
8.0% < 9.0% | 2,547,819 | 2,219,917 | ||
9.0% < 10.0% | 112,829 | 3,337,952 | ||
10.0% or greater | 242,556 | 14,709,506 | ||
$ | 5,512,263 | $ | 41,992,352 |
Surrender Charge Expiration By Year: |
Fixed and Fixed Index Annuities Account Value |
Weighted Average Surrender Charge | ||
Out of Surrender Charge | $ | 4,514,723 | 0.00 | % |
2023 | 4,336,011 | 3.03 | % | |
2024 | 3,919,595 | 5.38 | % | |
2025 | 5,453,784 | 4.44 | % | |
2026 | 4,892,384 | 5.96 | % | |
2027 | 4,283,172 | 7.81 | % | |
2028 | 3,714,323 | 9.00 | % | |
2029 | 4,143,581 | 10.42 | % | |
2030 | 2,775,742 | 12.89 | % | |
2031 | 3,900,824 | 13.80 | % | |
2032 | 3,060,964 | 14.38 | % | |
2033 | 1,068,172 | 17.39 | % | |
2034 | 676,085 | 18.03 | % | |
2035 | 350,543 | 18.50 | % | |
2036 | 196,242 | 18.99 | % | |
2037 | 113,435 | 19.50 | % | |
2038 | 105,035 | 20.00 | % | |
$ | 47,504,615 | 7.92 | % |
December 31, 2022 | December 31, 2021 | |||||||
Carrying Amount | Percent |
Carrying Amount | Percent | |||||
Fixed maturity securities: | ||||||||
U.S. Government and agencies | $ | 169,071 | 0.4 | % | $ | 1,078,746 | 1.9 | % |
States, municipalities and territories | 3,822,943 | 8.5 | % | 3,758,761 | 6.5 | % | ||
Foreign corporate securities and foreign governments | 616,938 | 1.4 | % | 375,097 | 0.6 | % | ||
Corporate securities | 20,201,774 | 44.8 | % | 32,631,189 | 57.0 | % | ||
Residential mortgage backed securities | 1,366,927 | 3.0 | % | 1,125,049 | 2.0 | % | ||
Commercial mortgage backed securities | 3,447,075 | 7.6 | % | 4,682,900 | 8.2 | % | ||
Other asset backed securities | 5,155,254 | 11.4 | % | 5,146,567 | 9.0 | % | ||
Total fixed maturity securities | 34,779,982 | 77.1 | % | 48,798,309 | 85.2 | % | ||
Mortgage loans on real estate | 6,778,977 | 15.0 | % | 5,650,480 | 9.9 | % | ||
Real estate investments | 1,056,063 | 2.3 | % | 337,939 | 0.6 | % | ||
Limited partnerships and limited liability companies | 1,266,779 | 2.8 | % | 520,120 | 0.9 | % | ||
Derivative instruments | 431,727 | 1.0 | % | 1,277,480 | 2.2 | % | ||
Other investments | 829,900 | 1.8 | % | 690,344 | 1.2 | % | ||
Total investments, net of modified coinsurance investments | 45,143,428 | 100.0 | % | 57,274,672 | 100.0 | % | ||
Coinsurance investments (a) | 6,181,870 | 3,101,832 | ||||||
Total investments | $ | 51,325,298 | $ | 60,376,504 |
NAIC Designation |
Amortized Cost |
Carrying Amount | Percent | Rating Agency Rating |
Amortized Cost |
Carrying Amount | Percent | ||||||
1 | $ | 24,466,961 | $ | 21,752,775 | 62.5 | % | Aaa/Aa/A | $ | 24,462,459 | $ | 21,723,282 | 62.5 | % |
2 | 14,185,506 | 12,398,001 | 35.7 | % | Baa | 14,228,490 | 12,434,302 | 35.7 | % | ||||
3 | 562,190 | 490,198 | 1.4 | % | Ba | 554,605 | 485,166 | 1.4 | % | ||||
4 | 109,409 | 91,495 | 0.3 | % | B | 94,185 | 79,058 | 0.2 | % | ||||
5 | 61,721 | 36,738 | 0.1 | % | Caa | 20,020 | 18,540 | 0.1 | % | ||||
6 | 14,636 | 10,775 | - | % | Ca and lower | 40,664 | 39,634 | 0.1 | % | ||||
39,400,423 | 34,779,982 | 100.0 | % | 39,400,423 | 34,779,982 | 100.0 | % | ||||||
Coinsurance investments (a) | 5,465,596 | 5,024,635 | Coinsurance investments (a) | 5,465,596 | 5,024,635 | ||||||||
$ | 44,866,019 | $ | 39,804,617 | $ | 44,866,019 | $ | 39,804,617 |
General Description (a) |
Amortized Cost | Allowance for Credit Losses | Amortized Cost, Net of Allowance |
Net Unrealized Losses, Net of Allowance | Fair Value | |||||
States, municipalities and territories | $ | 20,657 | $ | - | $ | 20,657 | $ | (3,344) | $ | 17,313 |
Corporate securities - Public securities | 20,860 | - | 20,860 | (1,050) | 19,810 | |||||
Corporate securities - Private placement securities | 10,646 | (3,214) | 7,432 | - | 7,432 | |||||
Residential mortgage backed securities | 25,095 | (133) | 24,962 | (2,954) | 22,008 | |||||
Commercial mortgage backed securities | 41,899 | - | 41,899 | (2,752) | 39,147 | |||||
Other asset backed securities | 2,314 | - | 2,314 | - | 2,314 | |||||
Collateralized loan obligations | 103,907 | - | 103,907 | (21,239) | 82,668 | |||||
$ | 225,378 | $ | (3,347) | $ | 222,031 | $ | (31,339) | $ | 190,692 |
December 31, 2022 | December 31, 2021 | |||||||
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value | |||||
Available for sale: | ||||||||
U.S. Government and agencies | $ | 173,638 | $ | 169,071 | $ | 1,046,029 | $ | 1,078,746 |
States, municipalities and territories | 4,356,191 | 3,822,943 | 3,325,468 | 3,758,761 | ||||
Foreign corporate securities and foreign governments | 680,263 | 616,938 | 353,198 | 375,097 | ||||
Corporate securities: | ||||||||
Capital goods | 1,601,113 | 1,395,595 | 2,329,169 | 2,666,627 | ||||
Consumer discretionary | 5,086,479 | 4,320,219 | 6,132,199 | 6,946,585 | ||||
Energy | 1,219,370 | 1,111,891 | 1,968,576 | 2,214,513 | ||||
Financials | 6,467,052 | 5,634,229 | 6,998,286 | 7,714,869 | ||||
Government non-guaranteed | 202,740 | 179,440 | 471,015 | 541,233 | ||||
Industrials | 166,061 | 138,999 | 377,631 | 425,201 | ||||
Information technology | 1,344,461 | 1,160,067 | 1,718,596 | 1,918,197 | ||||
Materials | 1,169,188 | 1,021,288 | 1,672,144 | 1,875,276 | ||||
Telecommunications | 1,306,495 | 1,090,868 | 1,569,176 | 1,756,741 | ||||
Transportation | 1,100,681 | 975,393 | 1,312,909 | 1,454,391 | ||||
Utilities | 3,620,946 | 3,115,520 | 4,156,578 | 4,716,397 | ||||
Other | 58,184 | 58,265 | 350,592 | 401,159 | ||||
Residential mortgage backed securities: | ||||||||
Government agency | 806,999 | 754,349 | 455,136 | 500,698 | ||||
Prime | 387,838 | 334,613 | 537,559 | 544,084 | ||||
Alt-A | 54,910 | 58,091 | 59,129 | 75,361 | ||||
Non-qualified mortgage | 169,847 | 157,960 | - | - | ||||
Other | 62,235 | 61,914 | 4,954 | 4,906 | ||||
Commercial mortgage backed securities: | ||||||||
Government agency | 170,307 | 157,903 | 380,339 | 415,026 | ||||
Non-agency | 3,668,300 | 3,289,172 | 4,169,970 | 4,267,874 | ||||
Other asset backed securities: | ||||||||
Auto | 44,450 | 41,896 | 218,106 | 222,364 | ||||
Consumer discretionary | 122,068 | 118,843 | - | - | ||||
Financials | 283,238 | 252,493 | 4,441 | 4,887 | ||||
Collateralized loan obligations | 4,071,929 | 3,775,347 | 3,789,984 | 3,745,452 | ||||
Other | 1,005,440 | 966,675 | 1,088,751 | 1,173,864 | ||||
39,400,423 | 34,779,982 | 44,489,935 | 48,798,309 | |||||
Coinsurance investments (a) | 5,465,596 | 5,024,635 | 2,509,248 | 2,507,634 | ||||
$ | 44,866,019 | $ | 39,804,617 | $ | 46,999,183 | $ | 51,305,943 |
December 31, 2022 | December 31, 2021 | |||||||
Principal | Percent | Principal | Percent | |||||
Property type distribution | ||||||||
Commercial mortgage loans: | ||||||||
Office | $ | 267,502 | 4.0 | % | $ | 287,557 | 5.1 | % |
Medical Office | 10,265 | 0.1 | % | 10,827 | 0.2 | % | ||
Retail | 878,352 | 13.0 | % | 1,016,101 | 18.0 | % | ||
Industrial/Warehouse | 853,215 | 12.6 | % | 924,779 | 16.3 | % | ||
Apartment | 893,910 | 13.2 | % | 854,580 | 15.1 | % | ||
Hotel | 285,271 | 4.2 | % | 283,500 | 5.0 | % | ||
Mixed Use/Other | 200,756 | 3.0 | % | 217,970 | 3.9 | % | ||
Agricultural mortgage loans | 567,630 | 8.4 | % | 408,135 | 7.2 | % | ||
Residential mortgage loans | 2,807,652 | 41.5 | % | 1,652,910 | 29.2 | % | ||
6,764,553 | 100.0 | % | 5,656,359 | 100.0 | % | |||
Coinsurance investments (a) | 171,633 | 37,817 | ||||||
$ | 6,936,186 | $ | 5,694,176 |
Commercial | Agricultural | |||||
Amortized Cost |
Average LTV |
Amortized Cost |
Average LTV | |||
As of December 31, 2022: | ||||||
Debt Service Coverage Ratio: | ||||||
Greater than or equal to 1.5 | $ | 2,358,793 | 53% | $ | 266,695 | 45% |
Greater than or equal to 1.2 and less than 1.5 | 505,644 | 61% | 236,589 | 48% | ||
Greater than or equal to 1.0 and less than 1.2 | 475,315 | 50% | 15,075 | 39% | ||
Less than 1.0 | 44,756 | 66% | 47,604 | 33% | ||
3,384,508 | 54% | 565,963 | 45% | |||
Coinsurance investments (a) | 170,050 | 61% | - | -% | ||
$ | 3,554,558 | 54% | $ | 565,963 | 45% | |
As of December 31, 2021: | ||||||
Debt Service Coverage Ratio: | ||||||
Greater than or equal to 1.5 | $ | 2,491,464 | 55% | $ | 180,113 | 49% |
Greater than or equal to 1.2 and less than 1.5 | 555,055 | 65% | 202,031 | 48% | ||
Greater than or equal to 1.0 and less than 1.2 | 466,517 | 53% | 16,304 | 44% | ||
Less than 1.0 | 77,948 | 65% | 8,551 | 59% | ||
3,590,984 | 56% | 406,999 | 48% | |||
Coinsurance investments (a) | 37,518 | 51% | - | -% | ||
$ | 3,628,502 | 56% | $ | 406,999 | 48% |
December 31, 2022 | ||||||||
Commercial | Agricultural | Residential | Total | |||||
Credit exposure - by payment activity | ||||||||
Performing | $ | 3,389,271 | $ | 564,495 | $ | 2,773,251 | $ | 6,727,017 |
In workout | - | - | - | - | ||||
Delinquent | - | 3,135 | 34,401 | 37,536 | ||||
Principal outstanding | 3,389,271 | 567,630 | 2,807,652 | 6,764,553 | ||||
Unamortized discounts and premiums, net | - | - | 55,917 | 55,917 | ||||
Deferred fees and costs, net | (4,763) | (1,667) | 1,909 | (4,521) | ||||
Amortized cost | 3,384,508 | 565,963 | 2,865,478 | 6,815,949 | ||||
Valuation allowance | (22,428) | (1,021) | (13,523) | (36,972) | ||||
Carrying value | 3,362,080 | 564,942 | 2,851,955 | 6,778,977 | ||||
Coinsurance investments (a) | 170,050 | - | - | 170,050 | ||||
$ | 3,532,130 | $ | 564,942 | $ | 2,851,955 | $ | 6,949,027 | |
December 31, 2021 | ||||||||
Commercial | Agricultural | Residential | Total | |||||
Credit exposure - by payment activity | ||||||||
Performing | $ | 3,595,314 | $ | 408,135 | $ | 1,645,905 | $ | 5,649,354 |
In workout | - | - | - | - | ||||
Delinquent | - | - | 7,005 | 7,005 | ||||
Principal outstanding | 3,595,314 | 408,135 | 1,652,910 | 5,656,359 | ||||
Unamortized discounts and premiums, net | - | - | 22,143 | 22,143 | ||||
Deferred fees and costs, net | (4,330) | (1,136) | 1,468 | (3,998) | ||||
Amortized cost | 3,590,984 | 406,999 | 1,676,521 | 5,674,504 | ||||
Valuation allowance | (17,926) | (519) | (5,579) | (24,024) | ||||
Carrying value | 3,573,058 | 406,480 | 1,670,942 | 5,650,480 | ||||
Coinsurance investments (a) | 37,518 | - | - | 37,518 | ||||
$ | 3,610,576 | $ | 406,480 | $ | 1,670,942 | $ | 5,687,998 |
A.M. Best | S&P | Fitch | |
Financial Strength Ratings | |||
American Equity Investment Life Insurance Company | A- (stable) | A- (stable) | A- (stable) |
American Equity Investment Life Insurance Company of New York | A- (stable) | A- (stable) | A- (stable) |
Eagle Life Insurance Company | A- (stable) | A- (stable) | A- (stable) |
Credit Ratings | |||
American Equity Investment Life Holding Company | bbb- (stable) | BBB- | BBB |
Senior unsecured debt | bbb- (stable) | BBB- | BBB- |
Perpetual, non-cumulative preferred stock | bb (stable) | BB | BB |
High | Low | Close | Dividend Declared | |
2022 | ||||
First Quarter | $44.49 | $35.05 | $39.91 | $0.00 |
Second Quarter | $42.18 | $32.65 | $36.57 | $0.00 |
Third Quarter | $43.55 | $33.22 | $37.29 | $0.00 |
Fourth Quarter | $46.76 | $28.05 | $45.62 | $0.36 |
2021 | ||||
First Quarter | $32.54 | $26.21 | $31.53 | $0.00 |
Second Quarter | $33.68 | $29.18 | $32.32 | $0.00 |
Third Quarter | $33.79 | $27.12 | $29.57 | $0.00 |
Fourth Quarter | $39.88 | $29.46 | $38.92 | $0.34 |
2020 | ||||
First Quarter | $34.16 | $9.07 | $18.80 | $0.00 |
Second Quarter | $27.09 | $14.76 | $24.71 | $0.00 |
Third Quarter | $27.32 | $19.06 | $21.99 | $0.00 |
Fourth Quarter | $34.25 | $22.37 | $27.66 | $0.32 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
American Equity Investment Life Holding Company published this content on 17 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 April 2023 20:43:50 UTC.